Kenya BioVax Institute Limited CEO, Dr. Michael Lusiola, represented Kenya Biovax Institute during the panel discussion on “Building a sustainable, realistic ecosystem” at the side event on Accelerating Vaccine and Therapeutic Production for Health Security in Africa #WHA77. The discussions kicked off with a message from Dr Tedros of World Health Organization. Afterwards, members explored what needs to happen to establish an enabling and robust ecosystem for the regional production of health products in Africa. During the deliberations, it was clear that Harmonized African Health Product Manufacturing signifies a pivotal step towards self-sufficiency and equitable healthcare access. By streamlining regulations, pooling resources, and fostering cross-border partnerships, we can strengthen local industries and ensure vital medicines reach every corner of the continent. Sustainability in African health product production is not a solitary endeavour—it’s about fostering resilience through collective efforts. In a realistic approach to sustainable health product production, collaboration is not just a key but a necessity. Your participation and contribution are vital in this journey.
Members present in the panel discussion were Frederik Kristensen of CEPI (Coalition for Epidemic Preparedness Innovations); Mar Martinez of EU Commission DE; Amy Dietterich of World Intellectual Property Organization – WIPO; Dr Sania Nishtar, Executive Director of Gavi, the Vaccine Alliance; Jeremy Farrar of World Health Organization; Dr. Abebe Genetu Bayih of Africa CDC; Prof. Ali Mrabet, Minister of Health, Tunisia; and Anne-Claire AMPROU the French Ambassador for hashtag#GlobalHealth.